COMTRIPSY 20

Comtripsy 20 Tablet 10’s is a combination medication that includes Trifluridine, a nucleoside metabolic inhibitor, and Tipiracil, a thymidine phosphorylase inhibitor. It is indicated for patients with metastatic colorectal cancer who have previously undergone other treatments, such as chemotherapy.

Comtripsy 20 Tablet 10’s combines Trifluridine and Tipiracil. Trifluridine is classified as a thymidine-based nucleoside analogue, functioning by inhibiting the growth and division of cancer cells. Tipiracil, on the other hand, acts as a thymidine phosphorylase inhibitor, which aids in prolonging the activity of trifluridine by slowing its breakdown in the body. This results in enhanced effectiveness against cancer cells.

It is essential to take Comtripsy 20 Tablet 10’s according to the dosage and duration prescribed by your healthcare provider. Consuming it at a consistent time with food is recommended to maximize its effectiveness. Possible side effects may include nausea, vomiting, diarrhea, abdominal pain, headaches, fatigue, and muscle or bone discomfort. Most of these side effects are not serious and typically resolve on their own. However, if they persist, it is important to reach out to your doctor. Seek immediate medical attention if you notice any allergic reactions or unusual symptoms.

Avoid abruptly discontinuing Comtripsy 20 Tablet 10’s to prevent adverse side effects. It is crucial to complete the entire course as directed by your physician. Notify your doctor if you have low white blood cell counts, anemia, bleeding disorders, or any liver or kidney issues.